- Home
- MESA vs OCUP Comparison
MESA vs OCUP Comparison
Compare MESA & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- OCUP
- Stock Information
- Founded
- MESA 1982
- OCUP 2018
- Country
- MESA United States
- OCUP United States
- Employees
- MESA N/A
- OCUP N/A
- Industry
- MESA Air Freight/Delivery Services
- OCUP Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- OCUP Health Care
- Exchange
- MESA Nasdaq
- OCUP Nasdaq
- Market Cap
- MESA 48.7M
- OCUP 53.1M
- IPO Year
- MESA 2018
- OCUP N/A
- Fundamental
- Price
- MESA $1.14
- OCUP $1.24
- Analyst Decision
- MESA
- OCUP Strong Buy
- Analyst Count
- MESA 0
- OCUP 3
- Target Price
- MESA N/A
- OCUP $18.67
- AVG Volume (30 Days)
- MESA 158.8K
- OCUP 92.2K
- Earning Date
- MESA 10-22-2024
- OCUP 11-11-2024
- Dividend Yield
- MESA N/A
- OCUP N/A
- EPS Growth
- MESA N/A
- OCUP N/A
- EPS
- MESA N/A
- OCUP N/A
- Revenue
- MESA $479,416,000.00
- OCUP $16,449,000.00
- Revenue This Year
- MESA $15.09
- OCUP N/A
- Revenue Next Year
- MESA $16.19
- OCUP $258.69
- P/E Ratio
- MESA N/A
- OCUP N/A
- Revenue Growth
- MESA N/A
- OCUP N/A
- 52 Week Low
- MESA $0.40
- OCUP $1.15
- 52 Week High
- MESA $1.89
- OCUP $3.40
- Technical
- Relative Strength Index (RSI)
- MESA 43.67
- OCUP 44.19
- Support Level
- MESA $1.14
- OCUP $1.24
- Resistance Level
- MESA $1.22
- OCUP $1.39
- Average True Range (ATR)
- MESA 0.06
- OCUP 0.06
- MACD
- MESA 0.00
- OCUP -0.00
- Stochastic Oscillator
- MESA 35.50
- OCUP 22.22
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.